#United States #California #biotechnology #NAGASE Group #Interfacial Consultants

NAGASE Group's Innovative Bio Research Facility in California

Recently, the NAGASE Group, headquartered in Tokyo, Japan, has made a significant leap in its research and development initiatives by opening a new bio research laboratory in California. This strategic move aims to harness the power of robotics and artificial intelligence (AI) to enhance the development of new materials, particularly in the bio sector. This initiative aligns with NAGASE Group's mid-term management strategy, ACE 2.0, which focuses on growth across four key pillars: foundation, focus, cultivation, and improvement.

The newly established facility operates under the umbrella of Interfacial Consultants LLC (IFC), a subsidiary based in Wisconsin, USA, boasting advanced capabilities in material and process development. With IFC's extensive experience and cutting-edge technology, this bio research center represents a pivotal step for NAGASE in expanding its bio industry footprint. Notably, this lab is equipped with state-of-the-art technologies and expertise in robotics and AI, which are poised to revolutionize the speed and efficiency of material development processes, particularly concerning microbial and enzyme exploration.

For years, NAGASE Group has been engaged in the development and manufacturing of industrial enzymes, food ingredients, cosmetics materials, and healthcare-related products. The integration of advanced robotics and AI into the Group's bioproducts research will drastically reduce the time required for repetitive validation processes, ultimately accelerating the introduction of new materials to the market.

The collaboration with NAGASE's manufacturing subsidiaries, including Nagase Vita Inc. and Nagase Diagnostics Inc., further emphasizes the strategic importance of this center. This synergy is intended to enhance the speed of new material development for the life sciences market. The NAGASE Group harbors a commitment to contributing to the extension of healthy life expectancies, encapsulating its mission of fostering a healthy and enriched lifestyle for people around the globe.

Overview of Interfacial Consultants LLC

• - Company Name: Interfacial Consultants LLC
• - Headquarters: Wisconsin, USA
• - CEO: Jeffrey Cernohous
• - Established: 2014
• - Business Scope: Advanced material and process development, new technology incubation

As a key component of NAGASE Group’s research and development functionality, IFC has been dedicated to advanced material research since joining the group in 2020. Collaborations have included innovative applications of water-soluble support materials developed for the 3D printing market. The new bio research facility will be managed by IFC, enhancing its operations and solidifying its role in the biotechnology research landscape.

Overview of NAGASE Vita Inc.

• - Company Name: Nagase Vita Inc.
• - Headquarters: Okayama City, Japan
• - CEO: Takahiko Bandai
• - Established: 1883
• - Business Scope: Development and manufacturing of food ingredients, pharmaceutical materials, cosmetic materials, health food ingredients, functional colorants, enzymes, and phospholipids

Overview of Nagase Diagnostics Inc.

• - Company Name: Nagase Diagnostics Inc.
• - Headquarters: Chuo City, Tokyo, Japan
• - CEO: Hironobu Makise
• - Established: 2024
• - Business Scope: Development and manufacturing of diagnostic drugs, diagnostic enzymes, and other life science materials

Contact Information

For inquiries about this initiative, visit NAGASE Group's website. For business-related questions, contact the NAGASE Group's Management Planning Department at TEL: 03-3665-3860 or email: [email protected]. For press inquiries, reach out to the NAGASE Group Corporate Relations Department at TEL: 080-8828-8676.